Login to Your Account



Other News To Note


Friday, June 8, 2012
• Foundation Medicine Inc., of Cambridge, Mass., said it signed a deal with Novartis AG, of Basel, Switzerland, to provide comprehensive genomic analysis in support of Novartis' clinical oncology programs. Financial terms were not disclosed.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription